Karimnejad Kaveh, Costa Dary J
Saint Louis University School of Medicine, Department of Otolaryngology-Head and Neck Surgery, 3635 Vista Avenue, St. Louis, MO 63110, United States.
Saint Louis University School of Medicine, Department of Otolaryngology-Head and Neck Surgery, 3635 Vista Avenue, St. Louis, MO 63110, United States; SSM Cardinal Glennon Children's Medical Center, 1465 South Grand Avenue, Room B-826, St. Louis, MO 63104, United States.
Int J Pediatr Otorhinolaryngol. 2015 Nov;79(11):1831-3. doi: 10.1016/j.ijporl.2015.08.017. Epub 2015 Aug 19.
Trisomy 18 and 13 are the most common autosomal trisomy disorders after Down syndrome. Given the high mortality rate (5-10% one-year survival), trisomy 18 and 13 were historically characterized as uniformly lethal and palliation was the predominant management approach. Management strategy has shifted with recognition that through medical and surgical intervention, children with trisomy 18 and 13 can achieve developmental milestones, live meaningful lives, and exhibit long-term survival. Otolaryngologic surgery in children with trisomy 18 and 13 has not been described. The objective of this article is to describe the role of the otolaryngologist in the management of children with trisomy 18 and 13.
Retrospective cohort analysis of the surgery registry for the Support Organization for Trisomy 18, 13 and Related Disorders for otolaryngologic surgeries reported from 1988 through June 1, 2014.
In the database of approximately 1349 children, 1380 procedures were reported, 231 (17%) of which were otolaryngologic. The most common otolaryngologic procedures were tympanostomy tube placement (57/231, 25%), cleft lip repair (40/231, 17%), tracheostomy (38/231, 16.5%), tonsillectomy and/or adenoidectomy (37/231, 16%), and cleft palate repair (30/231, 13%). Of the ten most common procedures reported, four were otolaryngologic.
Seventeen percent of procedures performed in children with trisomy 18 and 13 were otolaryngologic, highlighting the significant role of the otolaryngologist in the treatment of these patients. Surgical intervention may be considered as part of a balanced approach to patient care.
18三体和13三体是继唐氏综合征之后最常见的常染色体三体疾病。鉴于其高死亡率(1年生存率为5%-10%),18三体和13三体在历史上被认为是普遍致命的,姑息治疗是主要的管理方法。随着认识到通过医学和外科干预,18三体和13三体患儿能够达到发育里程碑、过上有意义的生活并实现长期生存,管理策略发生了转变。关于18三体和13三体患儿的耳鼻喉科手术尚未见报道。本文的目的是描述耳鼻喉科医生在18三体和13三体患儿管理中的作用。
对1988年至2014年6月1日期间18、13三体及相关疾病支持组织手术登记处报告的耳鼻喉科手术进行回顾性队列分析。
在约1349名儿童的数据库中,共报告了1380例手术,其中231例(17%)为耳鼻喉科手术。最常见的耳鼻喉科手术是鼓膜置管(57/231,25%)、唇裂修复(40/231,17%)、气管切开术(38/231,16.5%)、扁桃体切除术和/或腺样体切除术(37/231,16%)以及腭裂修复(30/231,13%)。在报告的十种最常见手术中,有四种是耳鼻喉科手术。
18三体和13三体患儿接受的手术中有17%是耳鼻喉科手术,这突出了耳鼻喉科医生在治疗这些患者中的重要作用。手术干预可被视为患者综合治疗方法的一部分。